These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23250713

  • 21. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL, Nicolay K, Koomans HA, Joles JA.
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [Abstract] [Full Text] [Related]

  • 22. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
    He YM, Feng L, Huo DM, Yang ZH, Liao YH.
    Nephrology (Carlton); 2013 Sep; 18(9):605-14. PubMed ID: 23869492
    [Abstract] [Full Text] [Related]

  • 23. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [Abstract] [Full Text] [Related]

  • 24. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE.
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [Abstract] [Full Text] [Related]

  • 25. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 26. Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.
    Hoque R, Rahman MS, Iqbal M.
    Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):44-8. PubMed ID: 20120778
    [Abstract] [Full Text] [Related]

  • 27. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [Abstract] [Full Text] [Related]

  • 28. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 29. Enalapril and prednisone in children with nephrotic-range proteinuria.
    Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.
    Pediatr Nephrol; 2000 Oct; 14(12):1088-91. PubMed ID: 11045392
    [Abstract] [Full Text] [Related]

  • 30. Cough induced by losartan with resolution after substitution with enalapril.
    Dashti-Khavidaki S, Faghihi T, Ahmadi F, Khalili H.
    Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
    [Abstract] [Full Text] [Related]

  • 31. Antiproteinuric effects of enalapril and losartan: a pilot study.
    White CT, Macpherson CF, Hurley RM, Matsell DG.
    Pediatr Nephrol; 2003 Oct; 18(10):1038-43. PubMed ID: 12920631
    [Abstract] [Full Text] [Related]

  • 32. Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
    Bryant CE, Rajai A, Webb NJA, Hogg RJ.
    Pediatr Nephrol; 2021 Oct; 36(10):3211-3219. PubMed ID: 33881639
    [Abstract] [Full Text] [Related]

  • 33. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA, Podracka L, Boor A, Jurkovic I, Mitro A, Kovacs L.
    Bratisl Lek Listy; 1999 Sep; 100(9):476-80. PubMed ID: 10645036
    [Abstract] [Full Text] [Related]

  • 34. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 35. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
    Ruggenenti P, Perna A, Tonelli M, Loriga G, Motterlini N, Rubis N, Ledda F, Rota S, Satta A, Granata A, Battaglia G, Cambareri F, David S, Gaspari F, Stucchi N, Carminati S, Ene-Iordache B, Cravedi P, Remuzzi G, ESPLANADE Study Group.
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease.
    Haas M, Yilmaz N, Schmidt A, Neyer U, Arneitz K, Stummvoll HK, Wallner M, Auinger M, Arias I, Schneider B, Mayer G.
    Kidney Blood Press Res; 1998 Nov; 21(1):66-9. PubMed ID: 9661139
    [Abstract] [Full Text] [Related]

  • 37. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
    Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.
    Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
    [Abstract] [Full Text] [Related]

  • 38. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP.
    J Am Soc Nephrol; 2007 Jun; 18(6):1889-98. PubMed ID: 17494885
    [Abstract] [Full Text] [Related]

  • 39. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 40. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.
    Rev Invest Clin; 2012 Oct 20; 64(4):315-21. PubMed ID: 23227581
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.